CRISPR Therapeutics
CRSP
#3301
Rank
C$4.68 B
Marketcap
$54.30
Share price
1.48%
Change (1 day)
-28.79%
Change (1 year)

Earnings for CRISPR Therapeutics (CRSP)

Earnings in 2024 (TTM): -C$0.5 Billion

According to CRISPR Therapeutics's latest financial reports the company's current earnings are C$35 Million. a decrease over its 2023 earnings that were of -C$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CRISPR Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 -C$0.51 Billion140.62%
2023 -C$0.21 Billion-76.83%
2022 -C$0.91 Billion-271.4%
2021 C$0.52 B-209.04%
2020 -C$0.49 Billion-617.12%
2019 C$93.45 M-140.93%
2018 -C$0.23 Billion146.86%
2017 -C$92.49 Million193.19%
2016 -C$31.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.2 Billion-60.60%๐Ÿ‡บ๐Ÿ‡ธ USA